0001104659-15-013147.txt : 20150223 0001104659-15-013147.hdr.sgml : 20150223 20150223214159 ACCESSION NUMBER: 0001104659-15-013147 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20150219 FILED AS OF DATE: 20150223 DATE AS OF CHANGE: 20150223 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Bellerophon Therapeutics, Inc. CENTRAL INDEX KEY: 0001600132 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 473116175 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 53 FRONTAGE ROAD, SUITE 301 CITY: HAMPTON STATE: NJ ZIP: 08827 BUSINESS PHONE: 908-574-4770 MAIL ADDRESS: STREET 1: 53 FRONTAGE ROAD, SUITE 301 CITY: HAMPTON STATE: NJ ZIP: 08827 FORMER COMPANY: FORMER CONFORMED NAME: Bellerophon Therapeutics LLC DATE OF NAME CHANGE: 20140213 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Linde North America, Inc. CENTRAL INDEX KEY: 0001505451 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36845 FILM NUMBER: 15641680 BUSINESS ADDRESS: STREET 1: 575 MOUNTAIN AVENUE CITY: MURRAY HILL STATE: NJ ZIP: 07974 BUSINESS PHONE: 908-771-4757 MAIL ADDRESS: STREET 1: 575 MOUNTAIN AVENUE CITY: MURRAY HILL STATE: NJ ZIP: 07974 4 1 a4.xml 4 X0306 4 2015-02-19 0 0001600132 Bellerophon Therapeutics, Inc. BLPH 0001505451 Linde North America, Inc. 575 MOUNTAIN AVENUE MURRAY HILL NJ 07974 0 0 1 0 Common Stock 2015-02-19 4 P 0 358916 12 A 1629804 D /s/ Jens Luehring, Chief Financial Officer and Director 2015-02-23